-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QuUGbZTMk195o5HXqbGd+CrX84TjMfQopJVxI6GZlytfEjOBSOE9b5ylq66LWPzG INNpK3P07WFfoyV1/mASPQ== 0001179110-04-017904.txt : 20040910 0001179110-04-017904.hdr.sgml : 20040910 20040910152943 ACCESSION NUMBER: 0001179110-04-017904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040817 FILED AS OF DATE: 20040910 DATE AS OF CHANGE: 20040910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2125544555 MAIL ADDRESS: STREET 1: 787 SEVENTH AVENUE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD CENTRAL INDEX KEY: 0000941841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27282 FILM NUMBER: 041025480 BUSINESS ADDRESS: STREET 1: 375 PARK AVE STREET 2: SUITE 1501 CITY: NEW YORK STATE: NY ZIP: 10152 BUSINESS PHONE: 2128324366 MAIL ADDRESS: STREET 1: 375 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10152 FORMER NAME: FORMER CONFORMED NAME: ROSENWALD LINDSAY MD DATE OF NAME CHANGE: 19950316 4 1 edgar.xml FORM 4 - X0202 4 2004-08-17 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHTT 0000941841 ROSENWALD LINDSAY A MD 787 SEVENTH AVENUE, 48TH FLOOR NEW YORK NY 10019 0 0 1 0 Common Stock 831213 I Owned by certain trusts for the benefit of the Reporting Person Common Stock 80 I By Spouse Common Stock 38 I Owned by June Street Company Common Stock 38 I Owned by Huntington Street Company Common Stock 33 I Owned by the Reporting Person's children Common Stock 2004-08-17 4 P 0 5000 0.80 A 2224521 D Common Stock 2004-08-17 4 P 0 5000 0.84 A 2229521 D Common Stock 2004-08-24 4 P 0 5000 0.80 A 2234521 D Common Stock 2004-09-03 4 P 0 5000 0.89 A 2239521 D Common Stock 2004-09-09 4 P 0 1000 0.95 A 2240521 D Warrants 16.83 2008-02-07 Common Stock 30851 30851 D Warrants 1.10 2009-01-30 Common Stock 486034 486034 D Series A Preferred Stock 0 Common Stock 221108 24322 D Shares owned by three trusts for the benefit of Dr. Rosenwald; however, Jay Lobell, and not Dr. Rosenwald has voting and dispositive control over the shares owned by these three trusts. Accordingly, Dr. Rosenwald is not a trustee of these trusts and disclaims beneficial ownership of these shares, except as to any pecuniary interest therein. A corporation of which the Reporting Person is the sole shareholder. Does not include 2,913,058 shares of common stock and 24,294 shares of Series A Convertible Preferred Stock (which is convertible into 220,854 shares of Common Stock), which are owned by certain trusts for the benefit of the Reporting Person's children. Dr. Rosenwald is not a trustee of these trusts and disclaims beneficial ownership of these shares, except as to any pecuniary interest therein. The shares owned by the trusts are reported on a separate Form 4, prepared by the trustee. Currently exercisable. No expiration date. 24,322 shares of Series A Convertible Preferred Stock convertible into 221,108 shares of common at no additional consideration. /s/ Lindsay A. Rosenwald, M.D. 2004-09-10 -----END PRIVACY-ENHANCED MESSAGE-----